Synchron COMMAND pivotal trial two-year follow-up results published
Data showed no device-related serious adverse events across participants, with functional usage metrics improving further from the early feasibility stage.
Synchron
2 entries7 月 2026
Synchron announces $150M Series D financing
The round will fund Synchrons pivotal COMMAND trial and commercialization efforts, among the largest single rounds in the BCI sector to date.